October 24, 2022

Ellen Wuyts was granted the Excellent Shotgun Poster Communication Prize at the 3rd International Caparica Conference on Leishmaniasis in Costa da Caparica, Portugal (Oct. 24-26, 2022). She received the prize for her presentation "Molecular basis for the potency and selectivity of TCMDC-143345, a promising lead for the development of novel anti-leishmanial drugs".


August 25, 2022

​Congratulations to Karen Claesen for successfully defending her PhD on August 25, 2022. 
Topic: The carboxypeptidase U system in atherosclerosis: Insights in carboxypeptidase U mediated pleiotropic effects of statins.


Januari 31, 2022

To all COVID and influenza virus researchers: we developed a high throughput assay to screen your inhibitors for TMPRSS2 affinity. Check this new technology/service offer here.

High-Throughput assay for TMPRSS2 inhibitor screening, based on human extracellular vesicles containing active and stable TMPRSS2 (EVZYM)


Januari 28, 2022

​Congratulations to Michelle De bruyn for successfully defending her PhD on January 28, 2022. 
Topic: Profiling of proteases as potential therapeutic targets – Focus on inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).


October 30, 2021

Yentl Van Rymenant was granted a Flash Talk Award at the virtual meeting on Serine Proteases in Pericellular Proteolysis and Signaling (Oct. 28–30, 2021). She received the award for her presentation "Design and characterization of fluorescent activity-based probes for imaging fibroblast activation protein (FAP) activity in the tumor microenvironment".


October 15, 2021

Karen Claesen was granted a Poster Award at the 4th European Congress on Thrombosis and Haemostasis ECTH2021 (Oct. 14-15, 2021). She received the award for her poster presentation "Evaluation of the carboxypeptidase U (CPU, TAFIa, CPB2) system in patients with SARS-CoV-2 infection".​


June 29, 2021

Congratulations to Emilie De Hert for successfully defending her PhD on June 29, 2021. 
Topic: Prolyl carboxypeptidase and its substrates: a potential role in metabolic disorders and the cardiovascular system.

Verdediging Emilie De Hert


Archives

December 11, 2020

Congratulations to Li Zeng for successfully defending her PhD on December 11, 2020. 
Topic: Development of new Recombinase Polymerase Amplification (RPA) and antigen-based diagnostic tools for the detection of Trypanosoma evansi infections.


September 7, 2020

Congratulations to Joachim Mertens for successfully defending his PhD on September 7, 2020. 
Topic: The carboxypeptidase U system in acute ischemic stroke: translation from bench to bedside.


June 22, 2020

Congratulations to Gwendolyn Vliegen for successfully defending her PhD on June 22, 2020. 
Topic: Proline-specific enzymes in infection and inflammation.

PhDdefenseGwendolynVliegen.JPG


April 28, 2020

Gwendolyn Vliegen completed her study on identifying new diagnostic biomarkers for sepsis. 


April 21, 2020

Our results on the activity of proline-specific enzymes in septic shock and their potential as biomarkers have been published in PLOS ONE.

Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2) by Gwendolyn Vliegen, Kaat Kehoe, An Bracke, Emilie De Hert, Robert Verkerk, Erik Fransen, Bart ‘s Jongers, Esther Peters, Anne-Marie Lambeir, Samir Kumar-Singh, Peter Pickkers, Philippe G. Jorens, Ingrid De Meester.


March, 2020

Joachim Mertens was granted a poster commendation award (Top 3 ranked poster) at the 2020 Gordon Research Conference on plasminogen activation and extracllular proteolysis in Ventura. He received the award for his poster “Selective inhibition of CPU reduces microvascular thrombosis in experimental rat stroke model”.


November, 2019

At the 2019 annual meeting of the Belgian Society of Thrombosis and Haemostasis, Joachim Mertens received the Paul Capel Prize for best oral presentation in the domain basic research for his presentation about the CPU system in experimental acute ischemic stroke in rats.


October, 2019

Michele De bruyn was granted an IPS Traval Award at the 11th General Meeting of the International Proteolysis Society in Mariánské Lázně, Czech Republic (29 September – 4 October).


April 26, 2019

Collaboration between HistoGeneX and the University of Antwerp brings new form of cancer treatment closer.